Impact of gene expression profiling-based risk stratification in patients with myeloma receiving initial therapy with lenalidomide and dexamethasone

Detection of specific chromosomal abnormalities by FISH and metaphase cytogenetics allows risk stratification in multiple myeloma; however, gene expression profiling (GEP) based signatures may enable more specific risk categorization. We examined the utility of 2 GEP-based risk stratification system...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Kumar, Shaji K., Uno, Hajime, Jacobus, Susanna J., Wier, Scott A. Van, Ahmann, Greg J., Henderson, Kimberly J., Callander, Natalie S., Haug, Jessica L., Siegel, David S., Greipp, Philip R., Fonseca, Rafael, Rajkumar, S. Vincent
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Hematology 2011
Konular:
Clinical Trials and Observations
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3204907/
https://ncbi.nlm.nih.gov/pubmed/21860025
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-03-342089
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller